Welcome : Guest
  • Only Report Titles
  • Titles & Keywords

VETERINARY VACCINES - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Veterinary Vaccines in US$ Million by the following Product segments - Companion Animal Vaccines (Canine Vaccines, & Feline Vaccines), and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines, & Other Animal Vaccines). The report provides separate comprehensive analytics for the US, Europe and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A seven-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Bayer HealthCare AG, Biogenesis-Bago, Boehringer Ingelheim GmbH, Heska Corporation, Imugene Limited, Indian Immunologicals Ltd., Lohmann Animal Health, Merck & Co., Inc., Intervet/Schering-Plough Animal Health, Merial Ltd., Pfizer, Inc., Embrex, Inc., Fort Dodge Animal Health, Protein Sciences Corporation, and Virbac Corporation. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1129
Price : $4500
Companies : 69
Pages : 416
Date : February 2011
Market Data Tables : 68

Complimentary Report Insights:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS

  VETERINARY VACCINES (Complete Report) Pages : 416   | $4500
 
  1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS.......15 $295  
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2  
   Data Interpretation & Reporting Level.......3
Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
  
   A. Companion Animal Vaccines.......4
B. Livestock Vaccines.......4
Porcine Vaccines.......4
Bovine Vaccines.......4
Poultry Vaccines.......4
Ovine Vaccines.......4
  
   Equine Vaccines.......5
Other Animal Vaccines.......5
  
  2. INDUSTRY OVERVIEW & OUTLOOK.......63 $495  
   Global Animal Health Care Industry - A Brief Review.......6
Table 1: Global Animal Health Products Market by Region (2008): Percentage Share Breakdown by Value Sales for North America, Europe, Latin America and Rest of World (includes corresponding Graph/Chart).......6

Table 2: Global Animal Health Products Market by Product Group (2008): Percentage Share Breakdown by Value sales for Parasiticides, Vaccines, Anti-Infectives, Medical Feed Additives and Other Pharmaceuticals (includes corresponding Graph/Chart).......6
1$350
   Animal Healthcare Market Grows Amidst Recession.......7
Veterinary Vaccines Industry Posts Moderate Growth.......7
Poultry Vaccines Industry: A Global Scenario.......7
1$100
   Improved Manufacturing Techniques.......8
Improved Analysis.......8
Scope of the Report.......8
1$100
  3. MARKET TRENDS & ISSUES.......9   
   Companion Animal Vaccines: Trailing on a High Growth Track.......9
OTC Market: A Potential Threat for Veterinarians.......9
Small Animal Practitioners Feel the Pinch of Recession.......9
Parasiticides, Systemic Agents To Drive The Market.......9
Taxonomy of Vaccines.......9
1$100
   Bird Flu – The Aftermath.......10
Vaccination – Critical for Controlling Avian Influenza Virus.......10
1$100
  4. PRODUCT OVERVIEW.......1111 $950  
   Vaccines - An Evolutionary Scan.......11
Contribution of Animal Research to Vaccine Production.......11
1$100
   Veterinary Medicines- A Brief Review.......12
Preventive Medicines.......12
Therapeutic Medicines.......12
Others.......12
Development of Vaccines.......12
1$100
   Production of Vaccines.......13
Veterinary Vaccines – An Essential Component of Animal Health Care.......13
1$100
   What Does A Veterinary Vaccine Do?.......14
Classification of Veterinary Vaccines.......14
Companion Animals Vaccines.......14
Canine Vaccines.......14
2$200
   Feline Vaccines.......161$100
   Livestock Vaccines.......17
Bovine Vaccines.......17
1$100
   Poultry Vaccines.......18
Ovine Vaccines.......18
1$100
   Porcine Vaccines.......19
Equine Vaccines.......19
Aquaculture Vaccines.......19
1$100
   A Tabular Analysis on Select Animal Diseases Controlled by Vaccines.......20
Vaccination and Its Reactions.......20
Veterinary Vaccines- Latest Breakthroughs.......20
Marker vaccines.......20
DNA vaccines.......20
1$100
   Gene-deleted vaccines.......21
Viral-vectored vaccines.......21
1$100
  5. NOTES ON SELECT ANIMAL DISEASES.......224 $395  
   Brucellosis.......22
Tuberculosis.......22
Johne’s disease.......22
Spirochete Associated Diseases.......22
1$100
   Respiratory Disease in Goats, Sheep, and Cattle.......23
Porcine Respiratory Diseases.......23
Mastitis.......23
African Swine Fever.......23
1$100
   Avian Influenza.......24
East Coast Fever.......24
Hemorrhagic Septicemia.......24
Foot-And-Mouth Disease.......24
Japanese Encephalitis.......24
1$100
   Rift Valley Fever.......25
Equine Virus.......25
1$100
  6. PRODUCT INNOVATIONS/INTRODUCTIONS.......2610 $595  
   Intervet/Schering-Plough Animal Health Introduces a New Web Site for Innovax
  recombinant Vaccines Product Line.......26
Pfizer Animal Health Introduces the First E. Coli Bacterial Extract Vaccine.......26
Intervet Schering-Plough Animal Health Re-Launches EQUILIS® StrepE for Horses.......26
Boehringer Ingelheim Vetmedica Launches Single Shot 3FLEX combination package
  PL.......26
Pfizer Animal Health Launches INFORCE™ 3.......26
1$100
   Boehringer Ingelheim Introduces Ingelvac CircoFLEX® in Russia.......27
Pfizer Animal Health Introduces Bopriva® for Bull and Beef Market in NZ.......27
GALVmed, Inter-African Bureau for Animal Resources Launch ECF Vaccine.......27
1$100
   BIVI launches Five New Variants of Vetera® Vaccines.......28
Hipra Announces Launch of Suiseng®.......28
Aceto Corporation Receives Approval to Sell Suppliera[euro]™ in the US.......28
1$100
   Intervet Schering-Plough Unleashes NOBIVAC Lyme Vaccine for Dogs.......29
Intervet Schering-Plough Animal Health Introduces PORCILIS PCV Vaccine.......29
Lohmann Launches AviPro® MEGAN®VAC Vaccination for Salmonella Disease.......29
Intervet Schering Plough Animal Health Introduces Circovirosis Vaccine.......29
Pfizer Animal Health Develops Inovocox® Vaccine.......29
1$100
   Intervet/Schering-Plough Animal Health Launches Bravoxin 10.......30
Bioject and Merial Rolls Out Derma-Vac NF.......30
Defra to Launch Bovine Tuberculosis Vaccine.......30
1$100
   Intervet International Develops Bluetongue Vaccine.......31
Hester Biosciences Unveils Anti-Coryza Vaccine.......31
Intervet/Schering-Plough Animal Health Introduces Bovilis BTV8 Vaccine.......31
Tecnovax Develops Vaccine for Salmon Virus.......31
Tamil Nadu Veterinary and Animal Science University and The Indian Veterinary Research
  Institute Develop Vaccine.......31
Lohmann Animal Health Develops AviPro IBD Xtreme.......31
1$100
   Intervet/Schering-Plough Animal Health Launches EquiRab™.......32
Lohmann Animal Health Introduces Larger Doses of AviPro® ViBursa CE.......32
Lohmann Animal Health International Rolls Out AviBlue.......32
1$100
   Fort Dodge Animal Health Unveils West Nile-Innovator DNA.......33
Univet Agricultural Products Introduces Coglapest.......33
Intervet/Schering-Plough Animal Health Launches Porcilis® COLI 6C.......33
Pfizer Animal Health Unveils FluSure® XP Defense System.......33
1$100
   Pfizer Animal Health Launches Improvac®.......34
Intervet/Schering-Plough Animal Health Develops Onset™ 5 Intranasal (IN)
  Vaccine.......34
Merial Rolls Out BTVPUR AlSap 8.......34
1$100
   Pfizer Animal Health Introduces FarrowSure® GOLD and FarrowSure® GOLD B.......35
Schering-Plough Animal Health Unveils CAVALRY 9.......35
Lohmann Animal Health Develops BTO2 REO Vaccine.......35
1$100
  7. PRODUCT INNOVATIONS/INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER.......364 $395  
   Agroinsuvet Introduces New Vaccines.......36
Merial Rolls Out Vaxxitek® HVT+IBD Hatchery Vaccine for Poultry Industry.......36
Intervet & Friedrich-Loeffler-Institute Develop Dual Vaccine Prototype for
  Birds.......36
Schering-Plough Receives USDA License for its Rhusigen™ Erysipelas Vaccine.......36
1$100
   USDA Approves Use of PreveNile™ Vaccine for Horses.......37
Fort Dodge Animal Health Develops Reverse Genetics Avian Vaccine.......37
Boehringer Ingelheim’s Swine Vaccine Gains Approval in Australia.......37
Merial Limited Gets USDA Approval for DNA Vaccine for Melanoma in Dogs.......37
1$100
   Embrex’s Poultry Vaccine Inovocox Gets USDA Approval.......38
Skystar Bio-Pharmaceutical Develops Avian Influenza Vaccine.......38
United States Department of Agriculture Grants Conditional License for Necrotic
  Enteritis Vaccine.......38
1$100
   Fort Dodge Receives USDA License for Pyramid®10.......39
USDA Licenses Use of Fort Dodge’s Suvaxyn® PCV2 Vaccine in Pigs.......39
USDA Grants Conditional License to Pfizer’s New Canine Vaccine.......39
1$100
  8. RECENT INDUSTRY ACTIVITY.......4021 $1450  
   Centegen Enters into Licensing Partnership with Merial.......40
The Ugandan Government Enters into Partnership with Brentec Vaccines
  International.......40
Pfizer Animal Health Kicks Off Equine Business Unit.......40
Pfizer Animal Health Acquires Microtek.......40
1$100
   GenVec Enters into Collaboration with Merial to Develop and Commercialize FMD
  Vaccine.......41
Pfizer Animal Health Inks Global Licensing Deal with Epitopix.......41
Indian Immunologicals Intends to Establish a New Facility in Hyderabad.......41
Pfizer Phases out Animal Vaccine Manufacturing Unit of Wyeth in the
  Netherlands.......41
1$100
   Vivalis Signs Commercial License for EB66® Cell Line Platform.......42
Ibio Grants Rights of iBioLaunch platform to Government Funded Project.......42
Intervet/Schering-Plough Animal Health Unveils Production Center at Boxmeer.......42
Globion India Announced Plans to Develop Eight New Vaccines.......42
Veterinary Services Department Intends to Upgrade VRI.......42
1$100
   VIVALIS Grants Rights of EB66® Cell Line To KYOTO BIKEN.......43
Vical Enters Into Agreement with GenomIdea for Development of DNA Vaccine.......43
Intervet/Schering-Plough Animal Health Unveils the New Freeze-drying and Specialized
  Central Filling Unit.......43
1$100
   Him Electronics Enters into Partnership with Hester Bioscience to Produce Animal
  Vaccines.......44
Intervet/Schering-Plough Animal Health Receives Approval for Nobivac Lepto4.......44
Biolex Enters into Collaboration With Merial for Research and Development.......44
1$100
   Intervet/Schering-Plough Animal Health Receives Full License from USDA for Nobivac®
  Vaccine.......45
Intercell Inks License Agreement with Boehringer.......45
Intervet/Schering-Plough Recalls PreveNile West Nile Virus Vaccine in the US.......45
Merial Gains Full License of ONCEPT™ from USDA.......45
1$100
   Virbac Acquires Veterinary Assets from Pfizer.......46
Harbin Pharmaceutical Group Holding Acquires Animal Vaccine Business From
  Pfizer.......46
Boehringer Ingelheim Acquires Certain Cattle Vaccines from Fort Dodge.......46
Virbac Acquires 30% Share in Santa Elena.......46
Merck and Sanofi-Aventis to Merge their Animal Health Business.......46
1$100
   Elanco to Take Over Pfizer’s Animal Health Products Portfolio.......47
Boehringer Ingelhei to Acquire Pfizer’s Fort Dodge Animal Health Unit.......47
ImmunoVaccine Inks Deal with Pfizer.......47
1$100
   Merck Merges with Schering-Plough.......48
Pfizer Acquires Wyeth.......48
Merial Receives Marketing License for BTVPUR AlSap 8 Vaccine.......48
Epitopix Obtains Approval to Sell Siderophore Receptor and Porin Vaccine.......48
1$100
   Phibro Animal Health Acquires Animal Health Division of Abic.......49
Fort Dodge Animal Health and Vivalis Sign Commercial License Deal.......49
Hester Biosciences Expands Gujarat Based Facility.......49
1$100
   Intervet/Schering-Plough Animal Health Replaces Bovilis® IBR Vaccine with Bovilis® IBR
  Marker Live.......50
Tangshan Yian Biological Engineering Wins Approval from Ministry of Agriculture of
  China.......50
Lohmann Animal Health International Signs an Agreement with Celldex
  Therapeutics.......50
Intervet/Schering-Plough Animal Health Starts New Manufacturing Facility.......50
1$100
   Laprovet Commences New Facility.......51
ImmunoVaccine Technologies and La Jolla Institute for Allergy & Immunology Enter into
  an Agreement.......51
Merial Signs a Toll Distribution and Manufacturing Agreement with Newport
  Laboratories.......51
1$100
   BOEHRINGER INGELHEIM Animal Health Signs Research License Deal with Vivalis.......52
AviTech Selects Merial as a Distributor and Service Provider.......52
Bayer Inks Agreement with Juvaris.......52
Pfizer Inks Agreement with ImmunoVaccine Technologies.......52
1$100
   BioVet Inaugurates BSL-4 Production Unit in India.......53
Vaxine to Take over Protein Sciences.......53
Pfizer Inaugurates a New Development Facility for Veterinary Vaccines.......53
Merial to Establish Animal Vaccine Manufacturing Plant.......53
BNC Bioniche Life Sciences Bags Approval to Sell Econiche Vaccines.......53
1$100
   Hind Bio-Pharmaceuticals to Establish Animal Vaccines Division.......54
Pfizer's Animal Health Unit Acquires Schering-Plough's Product License in
  Europe.......54
Grupo Mathiesen Takes Over Centro de Diagnostico Veterinario.......54
Harbin Veterinary Research Institute Opens Animal Vaccine Manufacturing Base.......54
1$100
   Bioject Medical Technologies Enters into a Long-Term Supply, Development and License
  Contract with Merial.......55
Vivalis SA Signs Letter of Intent with Intervet/ Schering-Plough.......55
Biochemiq Enters into Partnership with Labovet.......55
Microbix Biosystems Purchases Production Plant.......55
Beijing Veterinary Biological Product Factory Starts Operation in New Plant.......55
1$100
   Changzhou Tongtai Biopharmaceutical Sets Up Rabies Vaccine Facility.......56
Schering-Plough to Sell Health Products of Animals to Pfizer and Virbac.......56
Pfizer Group Establishes a Veterinary Vaccines Development Center.......56
Phylaxia to Acquire Gazdasagi Radio and Kozep-europai Gazterminal Zrt.......56
1$100
   Bayer HealthCare AG's Animal Health Unit Enters into Licensing Agreement with Juvaris
  BioTherapeutics.......57
Vivalis Enters into a Commercial License Contract with Virbac.......57
ImmunoVaccine Technologies Signs Licensing Agreement with Pfizer Animal Health.......57
Kaketsuken and Vivalis Extends Research Collaboration.......57
Heska Amends Distribution Contract with Agri Laboratories.......57
1$100
   Prevtec Microbia and Saskatchewan Research Council Receives Approval to Market and
  Manufacture Coliprotec.......58
Imugene and Merial Enter into an Agreement.......58
Celldex Therapeutics Merges with AVANT Immunotherapeutics’ Subsidiary.......58
Ceva Sante Animale Acquires Delvet.......58
1$100
   Inovio Biomedical Signs Merger Agreement with VGX Pharmaceuticals.......59
Environmental Risk Management Authority Approves equine Influenza Vaccine.......59
Functional Technologies Commences Operations of Phyterra Bio.......59
Summit VetPharm Enters into Distribution Partnership with Webster Veterinary
  Unit.......59
1$100
   PerOs Receives Establishment and Bacterin License from USDA.......60
Wyeth's Fort Dodge Animal Health Unit Acquires Poultry Vaccines.......60
Boehringer Ingelheim Vetmedica Receives Approval for Express® FP and Express® Vaccines
  from the USDA.......60
1$100
  9. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER.......618 $595  
   Merial Bags Major Australian Contract.......61
United States Department of Agriculture Approves Intervet Vaccine.......61
Merial Pockets Ancare.......61
Heska Revises Distribution Agreement with AgriLabs.......61
1$100
   Animal Health International Acquires Kane Veterinary Supplies.......62
Industrial Equity Investments Pockets Arysta LifeScience.......62
Henry Schein Acquires W&J Dunlop.......62
Tecnovax Establishes New Facility.......62
Pingtung Agricultural to Set Up an Exclusive Veterinary Park.......62
Ouro Fino To Expand Veterinary Product Suite.......62
Alpharma Acquires Yantai Jinhai.......62
1$100
   Pfizer Animal Health Acquires Embrex.......63
Schering-Plough Acquires Intervet.......63
Schering-Plough Acquires Organon BioSciences.......63
Intervet Sets Up New Animal Vaccine Production Facility in Boxmeer.......63
1$100
   Crucell Licenses PER.C6® Technology to Pfizer Animal Health.......64
Central Veterinary Research Laboratory to Synthesize New Animal Vaccines.......64
Pfizer to Shut Down Omaha Animal Vaccine Center.......64
1$100
   IGI Licenses Novasomes to Novavax.......65
Bogor Agricultural Institute Collaborates with Shigeta Animal Pharmaceuticals.......65
Suguna Poultry Steps into Livestock Vaccine Production Business.......65
European Medicines Agency Grants Community Authorization for Nobilis Influenza
  H7N1.......65
1$100
   AVANT Immunotherapeutics & Pfizer Collaborate to Develop Animal Vaccines.......66
Intervet International Acquires FMD Vaccine Production Facility from Bayer
  Healthcare.......66
Canadian Food Inspection Agency Authorizes Bioniche E. Coli O157:H7 Cattle Vaccine for
  Field Use.......66
1$100
   Hemispherx Biopharma Acquires DOGS Molecule Patent.......67
Hind Industries to Establish Animal Vaccine Formulations Plant at Patiala.......67
Cryosite and Animal Health Australia Form Partnership.......67
Hester Pharmaceuticals Plans Capacity Expansion.......67
Biovet to Set up Animal Vaccine Plant in Karnataka.......67
Bogor Institute of Agricultureand Shigeta Establish JV for Production of CLOSE 5.1
  Vaccine.......67
1$100
   IPB Shigeta Acquires Bird Flu Vaccine Rights from MedImmune.......68
Bioject Medical Technologies Signs Three Agreements With Merial.......68
PetCARE Television Network signs Distribution Agreement with Butler Animal Health
  Supply.......68
Poultry Vaccine to be produced in Vladimir.......68
1$100
  10. RESEARCH AND DEVELOPMENT IN RECENT PAST.......695 $395  
   Scientists Develop New Vaccine Against Disease Related to PCV2.......69
Auburn University and Vaxin Researchers Develop Avian Flu Vaccine.......69
UK Researchers Develop In-Shell Vaccine for Chicks.......69
1$100
   Researchers in Vietnam Decode the H5N1 Virus Gene.......70
Pittsburgh Researchers Create Avian Flu Vaccine from H5N1 Virus.......70
University of Warwick Develops Protecting Virus Method.......70
1$100
   New Treatment Measure Against Ovine Salmonella & Brucellosis.......71
ICAR Develops Indigenous Bird Flu Vaccine.......71
St. Jude Develops Flu Virus Vaccine through Reverse Genetics.......71
Researchers Develop Vaccine for Swine Disease.......71
1$100
   Researchers Develop Experimental Vaccine Against 1918 Influenza Virus.......72
Study Proves Effectiveness of Intradermal Vaccine Administration in Rabbits.......72
1$100
   CEL-SCI’s CEL-1000 Peptide Shows Adjuvant Activity.......73
Progress in Vaccine for Canine Cancer.......73
1$100
  11. FOCUS ON SELECT GLOBAL PLAYERS.......746 $495  
   Bayer HealthCare AG (Germany).......74
Biogenesis-Bago (Argentina).......74
Boehringer Ingelheim GmbH (Germany).......74
1$100
   Heska Corporation (US).......75
Imugene Limited (Australia).......75
Indian Immunologicals Ltd (India).......75
1$100
   Lohmann Animal Health (US).......76
Merck & Co., Inc. (US).......76
1$100
   Intervet/Schering-Plough Animal Health (The Netherlands).......77
Merial Ltd. (US).......77
Pfizer, Inc. (US).......77
1$100
   Embrex, Inc. (US).......78
Fort Dodge Animal Health (US).......78
1$100
   Protein Sciences Corporation (US).......79
Virbac Corporation (US).......79
1$100
  12. GLOBAL MARKET PERSPECTIVE.......80   
   Table 3: World Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......801$350
   Table 4: World Historic Review Veterinary Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......811$350
   Table 5: World 11-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart).......821$350
   Table 6: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......831$350
   Table 7: World Historic Review for Companion Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......841$350
   Table 8: World 11-Year Perspective for Companion Animal Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......851$350
   Table 9: World Recent Past, Current & Future Analysis for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......861$350
   Table 10: World Historic Review for Companion Animal Vaccines by Product Segment- Canine Vaccines & Feline Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......87

Table 11: World 11-Year Perspective for Companion Animal Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Canine Vaccines & Feline Vaccines Markets for Years 2005, 2010 & 2015.......87
1$350
   Table 12: World Recent Past, Current & Future Analysis for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......881$350
   Table 13: World Historic Review for Canine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......891$350
   Table 14: World 11-Year Perspective for Canine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......901$350
   Table 15: World Recent Past, Current & Future Analysis for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......911$350
   Table 16: World Historic Review for Feline Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......921$350
   Table 17: World 11-Year Perspective for Feline Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart).......931$350
   Table 18: World Recent Past, Current & Future Analysis for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......941$350
   Table 19: World Historic Review for Livestock Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......951$350
   Table 20: World 11-Year Perspective for Livestock Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......961$350
   Table 21: World Recent Past, Current & Future Analysis for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......971$350
   Table 22: World Historic Review for Livestock Vaccines by Product Segment – Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......981$350
   Table 23: World 11-Year Perspective for Livestock Vaccines by Product Segment – Percentage Breakdown of Dollar Sales for Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines & Other Animal Vaccines Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......991$350
   Table 24: World Recent Past, Current & Future Analysis for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1001$350
   Table 25: World Historic Review for Porcine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1011$350
   Table 26: World 11-Year Perspective for Porcine Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1021$350
   Table 27: World Recent Past, Current and Future Analysis for Bovine Vaccines by Geographic Region – US, Europe & Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1031$350
   Table 28: World Historic Review for Bovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1041$350
   Table 29: World 11-Year Perspective for Bovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart).......1051$350
   Table 30: World Recent Past, Current & Future Analysis for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1061$350
   Table 31: World Historic Review for Poultry Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1071$350
   Table 32: World 11-Year Perspective for Poultry Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1081$350
   Table 33: World Recent Past, Current & Future Analysis for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1091$350
   Table 34: World Historic Review for Ovine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1101$350
   Table 35: World 11-Year Perspective for Ovine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart).......1111$350
   Table 36: World Recent Past, Current & Future Analysis for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1121$350
   Table 37: World Historic Review for Equine Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1131$350
   Table 38: World 11-Year Perspective for Equine Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1141$350
   Table 39: World Recent Past, Current & Future Analysis for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1151$350
   Table 40: World Historic Review for Other Animal Vaccines by Geographic Region – US, Europe and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1161$350
   Table 41: World 11-Year Perspective for Other Animal Vaccines by Geographic region – Percentage Breakdown of Dollar Sales for US, Europe and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1171$350
  13. THE UNITED STATES.......1184 $950  
   A. Market Analysis.......118
Current & Future Analysis.......118
H5N1 Virus: A Conundrum for the US Industry.......118
Rabies Cases in the US.......118
1$100
   B. Market Analytics.......119
Table 42: US Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......119
1$350
   Table 43: US Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1201$350
   Table 44: US 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1211$350
  14. EUROPE.......1226 $1950  
   Market Analysis.......122
Table 45: European Recent Past, Current & Future Analysis for Veterinary Vaccines by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......122
1$350
   Table 46: European Historic Review for Veterinary Vaccines by Geographic Region – France, Germany, Italy, United Kingdom and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1231$350
   Table 47: European 11-Year Perspective for Veterinary Vaccines by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, Italy, United Kingdom and Rest of Europe for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1241$350
   Table 48: European Recent Past, Current & Future for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1251$350
   Table 49: European Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1261$350
   Table 50: European 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for Years 2005, 2010 & 2015(includes corresponding Graph/Chart).......1271$350
  14a. FRANCE.......1283 $950  
   Market Analysis.......128
Table 51: French Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......128
1$350
   Table 52: French Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1291$350
   Table 53: French 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1301$350
  14b. GERMANY.......1313 $950  
   Market Analysis.......131
Table 54: German Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......131
1$350
   Table 55: German Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1321$350
   Table 56: German 11-Year Perspective for Veterinary Vaccines by Product Group/ Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines and Equine Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1331$350
  14c. ITALY.......1343 $950  
   Market Analysis.......134
Table 57: Italian Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......134
1$350
   Table 58: Italian Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1351$350
   Table 59: Italian 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1361$350
  14d. THE UNITED KINGDOM.......1373 $950  
   Market Analysis.......137
Table 60: UK Recent Past, Current & Future Analysis for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......137
1$350
   Table 61: UK Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1381$350
   Table 62: UK 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1391$350
  14e. REST OF EUROPE.......1405 $950  
   A. Market Analysis.......140
Current & Future Analysis 140 A Note on Danish Veterinary Services.......140
1$100
   The 2002 Standards of Danish Medicines recommend test for antibody inducing
  fragments in veterinary vaccines.......141
Hungary Vaccinates Birds Across Zoos.......141
Russia Mass-Produces Vaccines Against Avian Flu.......141
1$100
   B. Market Analytics.......142
Table 63: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Vaccines – by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......142
1$350
   Table 64: Rest of Europe Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1431$350
   Table 65: Rest of Europe 11-Year Perspective for Veterinary Vaccines by Product/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1441$350
  15. REST OF WORLD.......1458 $950  
   A. Market Analysis.......145
Current & Future Analysis.......145
Focus on Select Regions.......145
Canada.......145
Overview of Canadian Animal Health Industry.......145
Import and Manufacture of Veterinary Biologics.......145
First to Access E. coli 0157:H7 Vaccine.......145
1$100
   China.......146
A Glance at the Animal Vaccine Market in China.......146
1$100
   China Initiates Mass Vaccination Campaign Against Bird Flu Virus.......147
Australia.......147
A Note on Australian Veterinary Therapeutics Market.......147
India.......147
ICAR Develops Indigenous Bird Flu Vaccine.......147
Thailand.......147
Japan & Thailand to Cooperate for Developing Bird Flu Vaccine.......147
1$100
   Taiwan.......148
Taiwan’s Animal Healthcare Industry Under Scan.......148
Malaysia.......148
Malaysia Initiates Measures to Deal with Potential Flu Pandemic.......148
Kazakhstan.......148
Kazakhstan Takes Proactive Measures Against Bird Flu.......148
1$100
   North Korea.......149
North Korea Develops Bird Flu Vaccine.......149
Vietnam.......149
Vietnam Imports Bird Flu Vaccines.......149
Egypt.......149
Egypt Reports H5N1 Infection in Vaccinated Flocks.......149
Kenya.......149
Kenya Mass-Manufactures Vaccines Against Rift Valley Fever.......149
1$100
   B. Market Analytics.......150
Table 66: Rest of World Recent Past, Current & Future Analysis for Veterinary Vaccines - by Product Group/ Segment for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......150
1$350
   Table 67: Rest of World Historic Review for Veterinary Vaccines by Product Group/Segment – Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1511$350
   Table 68: Rest of World 11-Year Perspective for Veterinary Vaccines by Product Group/Segment – Percentage Breakdown of Dollar Sales for Companion Animal Vaccines (Canine Vaccines and Feline Vaccines) and Livestock Vaccines (Porcine Vaccines, Bovine Vaccines, Poultry Vaccines, Ovine Vaccines, Equine Vaccines and Other Animal Vaccines) Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....1521$350
COMPETITION 252$995
  
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 97)

Region/Country                 Players


The United States                 30   
Canada                             5
Japan                              3
Europe                            28 
     France                        3
     Germany                       8
     The United Kingdom            1
     Italy                         2
     Rest of Europe               14 
Asia-Pacific (Excluding Japan)    22 
Latin America                      5
Africa                             1
Middle-East                        3
Click here to request a full table of contents and more details on this project.		  
 
 

© Global Industry Analysts, Inc., USA. All Rights Reserved.
Visa Master American Verisign